z-logo
open-access-imgOpen Access
Noninvasive fibrosis marker can predict recurrence of hepatocellular carcinoma after radiofrequency ablation
Author(s) -
Hyun Woo Chung,
JeongHan Kim,
Young Jin Hwang,
Hong Seok Choi,
Soon Young Ko,
Won Hyeok Choe,
So Young Kwon
Publication year - 2016
Publication title -
the saudi journal of gastroenterology/saudi journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.608
H-Index - 32
eISSN - 1998-4049
pISSN - 1319-3767
DOI - 10.4103/1319-3767.173760
Subject(s) - medicine , hepatocellular carcinoma , hazard ratio , gastroenterology , radiofrequency ablation , univariate analysis , proportional hazards model , fibrosis , multivariate analysis , confidence interval , ablation
Tumor recurrence after curative therapy is common for patients with hepatocellular carcinoma (HCC). As fibrosis and chronic inflammation contribute to the progression of HCC, we aimed to identify the predictive value of inflammatory and fibrosis markers for HCC recurrence after curative therapy using radiofrequency ablation (RFA).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here